Thus, the aim of this study is to describe a comprehensive CYP21A2 mutation analysis in a cohort of classic CAH patients and to create a useful tool for clinicians and geneticists, necessary for the genetic diagnosis and management of not only Cypriot patients but also for international patients with 21-hydroxylase deficiency. The gene discussed is CYP21A2; the disease is congenital adrenal hyperplasia.